TRANSMIT ENT (01326) May Delay Publication of 2024/2025 Annual Results, Trading Expected to be Suspended from October 2

Stock News
Sep 19, 2025

TRANSMIT ENT (01326) announced that it may delay the publication of its 2024/2025 annual results. Should the company fail to publish its 2024/2025 annual results on or before September 30, 2025, the company's shares are expected to be suspended from trading on the Stock Exchange from 9:00 a.m. on October 2, 2025 (Thursday) until the company publishes its 2024/2025 annual results announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10